Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat

Jane K. Relton, Nancy J. Rothwell

Research output: Contribution to journalArticlepeer-review

Abstract

Interleukin-1 (IL-1) synthesis in the brain is stimulated by mechanical injury and IL-1 mimics some effects of injury, such as gliosis and neovascularization. We report that neuronal death resulting from focal cerebral ischaemia (middle cerebral artery occlusion, 24 h) is significantly inhibited (by 50%) in rats injected with a recombinant IL-1 receptor antagonist (IL-1ra, 10 μg, icv 30 min before and 10 min after ischaemia). Excitotoxic damage due to striatal infusion of an NMDA-receptor agonist (cis-2,4-methanoglutamate) was also markedly inhibited (71%) by injection of the IL-1ra. These data indicate that endogenous IL-1 is a mediator of ischaemic and excitotoxic brain damage, and that inhibitors of IL-1 action may be of therapeutic value in the treatment of acute or chronic neuronal death. © 1992.
Original languageEnglish
Pages (from-to)243-246
Number of pages3
JournalBrain Research Bulletin
Volume29
Issue number2
Publication statusPublished - Aug 1992

Keywords

  • Interleukin-1 Neurotoxicity Neuronal degeneration Excitotoxicity Ischaemia

Fingerprint

Dive into the research topics of 'Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat'. Together they form a unique fingerprint.

Cite this